Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients.

De Ciuceis C, Agabiti-Rosei C, Rossini C, Caletti S, Coschignano MA, Ferrari-Toninelli G, Ragni G, Cappelli C, Cerudelli B, Airò P, Scarsi M, Tincani A, Porteri E, Rizzoni D.

High Blood Press Cardiovasc Prev. 2018 Dec;25(4):369-378. doi: 10.1007/s40292-018-0279-7. Epub 2018 Sep 10.

PMID:
30203268
2.

Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept.

Piantoni S, Regola F, Scarsi M, Tincani A, Airò P.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):685. Epub 2018 Apr 13. No abstract available.

3.

Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans.

De Ciuceis C, Agabiti-Rosei C, Rossini C, Airò P, Scarsi M, Tincani A, Tiberio GAM, Piantoni S, Porteri E, Solaini L, Duse S, Semeraro F, Petroboni B, Mori L, Castellano M, Gavazzi A, Agabiti-Rosei E, Rizzoni D.

Blood Press. 2017 Aug;26(4):237-245. doi: 10.1080/08037051.2017.1292395. Epub 2017 Feb 15.

PMID:
28276721
4.

Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans.

De Ciuceis C, Rossini C, Airò P, Scarsi M, Tincani A, Tiberio GA, Piantoni S, Porteri E, Solaini L, Duse S, Semeraro F, Petroboni B, Mori L, Castellano M, Gavazzi A, Agabiti Rosei C, Agabiti Rosei E, Rizzoni D.

Am J Hypertens. 2017 Jan;30(1):51-60. Epub 2016 Sep 21.

PMID:
27653031
5.

Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.

De Ciuceis C, Rossini C, Tincani A, Airò P, Scarsi M, Agabiti-Rosei C, Ruggeri G, Caimi L, Ricotta D, Agabiti-Rosei E, Rizzoni D.

Blood Press. 2016 Dec;25(6):337-343. Epub 2016 May 19.

PMID:
27195656
6.

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis.

Piantoni S, Colombo E, Tincani A, Airò P, Scarsi M.

Clin Rheumatol. 2016 Apr;35(4):1065-9. doi: 10.1007/s10067-016-3185-1. Epub 2016 Jan 26.

PMID:
26809797
7.

Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept.

Colombo E, Scarsi M, Piantoni S, Tincani A, Airò P.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):37-41. Epub 2015 Dec 1.

PMID:
26633185
8.

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab.

Piantoni S, Scarsi M, Tincani A, Airò P.

Rheumatol Int. 2015 Sep;35(9):1571-3. doi: 10.1007/s00296-015-3295-0. Epub 2015 May 30. No abstract available.

PMID:
26024733
9.

CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et al.

Airò P, Colombo E, Piantoni S, Scarsi M.

Arthritis Rheumatol. 2015 May;67(8):2273-4. doi: 10.1002/art.39181. No abstract available.

10.

Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D.

Piantoni S, Andreoli L, Scarsi M, Zanola A, Dall'Ara F, Pizzorni C, Cutolo M, Airò P, Tincani A.

Lupus. 2015 Apr;24(4-5):490-8. doi: 10.1177/0961203314559090.

PMID:
25801892
11.

Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients.

Imberti L, Scarsi M, Zanotti C, Chiarini M, Bertoli D, Tincani A, Airò P.

J Transl Med. 2015 Jan 16;13:12. doi: 10.1186/s12967-014-0363-2.

12.

Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.

Scarsi M, Radice A, Pregnolato F, Ramoni V, Grava C, Bianchi L, Gerosa M, Mosca M, Ghirardello A, Tani C, Motta M, Quinzanini M, Tincani A, Ruffatti A, Migliorini P, Doria A, Meroni PL, Brucato A.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):848-54. Epub 2014 Oct 20.

PMID:
25327946
13.

Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity.

Scarsi M, Bosio C, Coccoli S, Barucco A, Tavelli G, Airò P.

Clin Rheumatol. 2014 Jun;33(6):873-5. doi: 10.1007/s10067-014-2605-3. Epub 2014 Apr 13.

PMID:
24728879
14.

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.

Scarsi M, Paolini L, Ricotta D, Pedrini A, Piantoni S, Caimi L, Tincani A, Airò P.

J Rheumatol. 2014 Apr;41(4):666-72. doi: 10.3899/jrheum.130905. Epub 2014 Mar 1.

PMID:
24584924
15.

Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis.

Scarsi M, Zanotti C, Chiarini M, Imberti L, Piantoni S, Frassi M, Tincani A, Airò P.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):204-10. Epub 2014 Jan 14.

PMID:
24428959
16.

Targeting CD4+CD28- T cells by blocking CD28 co-stimulation.

Airò P, Scarsi M.

Trends Mol Med. 2013 Jan;19(1):1-2. doi: 10.1016/j.molmed.2012.10.013. Epub 2012 Nov 23. No abstract available.

PMID:
23182698
17.

Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis.

Scarsi M, Ziglioli T, Airo' P.

J Rheumatol. 2011 Oct;38(10):2105-11. doi: 10.3899/jrheum.110386. Epub 2011 Aug 1.

PMID:
21807779
18.

Thymic and bone marrow output in patients with common variable immunodeficiency.

Serana F, Airò P, Chiarini M, Zanotti C, Scarsi M, Frassi M, Lougaris V, Plebani A, Caimi L, Imberti L.

J Clin Immunol. 2011 Aug;31(4):540-9. doi: 10.1007/s10875-011-9526-6. Epub 2011 Apr 14.

PMID:
21491094
19.

Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.

Costa S, Mondini M, Caneparo V, Afeltra A, Airò P, Bellisai F, Faggioli P, Gerli R, Lotzniker M, Meroni PL, Morozzi G, Radice A, Riccieri V, Scarsi M, Sebastiani GD, Sinico RA, Tincani A, Gariglio M, Landolfo S.

Rheumatology (Oxford). 2011 Apr;50(4):674-81. doi: 10.1093/rheumatology/keq372. Epub 2010 Dec 6.

PMID:
21134960
20.

Type I interferons in systemic autoimmunity.

Sozzani S, Bosisio D, Scarsi M, Tincani A.

Autoimmunity. 2010 Apr;43(3):196-203. doi: 10.3109/08916930903510872. Review.

PMID:
20298124
21.

Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response.

Scarsi M, Ziglioli T, Airò P.

J Rheumatol. 2010 May;37(5):911-6. doi: 10.3899/jrheum.091176. Epub 2010 Mar 15.

PMID:
20231200
22.

The number of circulating recent thymic emigrants is severely reduced 1 year after a single dose of alemtuzumab in renal transplant recipients.

Scarsi M, Bossini N, Malacarne F, Valerio F, Sandrini S, Airò P.

Transpl Int. 2010 Aug;23(8):786-95. doi: 10.1111/j.1432-2277.2010.01052.x. Epub 2010 Feb 3.

23.

Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid.

Podvinec M, Lim SP, Schmidt T, Scarsi M, Wen D, Sonntag LS, Sanschagrin P, Shenkin PS, Schwede T.

J Med Chem. 2010 Feb 25;53(4):1483-95. doi: 10.1021/jm900776m.

PMID:
20108931
24.

European attempts for the standardisation of the antiphospholipid antibodies.

Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL.

Lupus. 2009 Sep;18(10):913-9. doi: 10.1177/0961203309106919.

PMID:
19671792
25.

The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions.

Airo P, Scarsi M, Malagoli A, Carella G, Izzo I, Carosi G, Torti C.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):361-2. doi: 10.1097/QAI.0b013e3181aa1382. No abstract available.

PMID:
19553774
26.

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.

Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, Airò P.

J Rheumatol. 2009 Jun;36(6):1188-94. doi: 10.3899/jrheum.081246. Epub 2009 May 15. Review.

PMID:
19447932
27.

Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis.

Airò P, Ghidini C, Zanotti C, Scarsi M, Cattaneo R, Caimi L, Imberti L.

J Rheumatol. 2008 Nov;35(11):2192-200. Epub 2008 Oct 1.

PMID:
18843779
28.

An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility.

Antonioli CM, Bua G, Frigè A, Prandini K, Radici S, Scarsi M, Danieli E, Malvicini A, Airo P.

Clin Rheumatol. 2009 Feb;28(2):159-65. doi: 10.1007/s10067-008-1006-x. Epub 2008 Sep 16.

PMID:
18795394
29.

[Long-term effects of cyclic therapy with iloprost in systemic sclerosis].

Scarsi M, Rossi M, Danieli E, Frigè A, Grottolo A, Zambruni A, Airò P.

Reumatismo. 2008 Apr-Jun;60(2):114-9. Italian.

30.

Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.

Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airò P, Cattaneo R, Franceschini F.

Lupus. 2008 Aug;17(8):727-32. doi: 10.1177/0961203308089442.

PMID:
18625650
31.
32.

Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners.

Airò P, Tabaglio E, Frassi M, Scarsi M, Danieli E, Rossi M.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):878-80.

PMID:
18173923
33.

Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.

Airò P, Rossi M, Scarsi M, Danieli E, Grottolo A, Zambruni A.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):722-7.

PMID:
18078620
34.

Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis.

Airo' P, Scarsi M, Rossi M, Mondini M.

Rheumatol Int. 2008 May;28(7):703-7. Epub 2007 Dec 8.

PMID:
18066551
35.

Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease.

Tincani A, Scarsi M, Franceschini F, Cattaneo R.

Isr Med Assoc J. 2007 Jul;9(7):553-4. No abstract available.

36.

Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.

Airò P, Danieli E, Rossi M, Frassi M, Cavazzana I, Scarsi M, Grottolo A, Franceschini F, Zambruni A.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):293-6.

PMID:
17543156
37.

Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach.

Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rücker C.

Mol Pharmacol. 2007 Feb;71(2):398-406. Epub 2006 Nov 2.

PMID:
17082235
38.

Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block.

Airo' P, Scarsi M, Brucato A, Benicchi T, Malacarne F, Cavazzana I, Danieli E, LiDestri M, Motta M, Caimi L, Tincani A, Imberti L.

Lupus. 2006;15(9):553-61.

PMID:
17080909
39.

2D QSAR of PPARgamma agonist binding and transactivation.

Rücker C, Scarsi M, Meringer M.

Bioorg Med Chem. 2006 Aug 1;14(15):5178-95. Epub 2006 May 2.

PMID:
16650995
40.

Efficient electrostatic solvation model for protein-fragment docking.

Majeux N, Scarsi M, Caflisch A.

Proteins. 2001 Feb 1;42(2):256-68.

PMID:
11119650
41.

Hydrophobicity at the surface of proteins.

Scarsi M, Majeux N, Caflisch A.

Proteins. 1999 Dec 1;37(4):565-75.

PMID:
10651272
42.

Exhaustive docking of molecular fragments with electrostatic solvation.

Majeux N, Scarsi M, Apostolakis J, Ehrhardt C, Caflisch A.

Proteins. 1999 Oct 1;37(1):88-105.

PMID:
10451553
43.

Surgical treatment of scoliosis associated with myelomeningocele.

Stella G, Ascani E, Cervellati S, Bettini N, Scarsi M, Vicini M, Magillo P, Carbone M.

Eur J Pediatr Surg. 1998 Dec;8 Suppl 1:22-5.

PMID:
9926319
44.

CT-guided needle localization of lung nodules for thoracoscopic resection.

Sartoris F, Cittadini G, Saitta S, Ratto GB, Scarsi MP, Garlaschi G, Derchi LE.

Eur Radiol. 1996;6(4):420-4.

PMID:
8798014
45.

Hip deformity and dislocation in spina bifida.

Canale G, Scarsi M, Mastragostino S.

Ital J Orthop Traumatol. 1992;18(2):155-65.

PMID:
1289281
46.

[Jarcho-Levin syndrome. Description of a familial case and review of the literature].

Bellini C, Scarsi M, Ruffa G, De Logu A, Bonioli E.

Minerva Pediatr. 1987 Sep 30;39(17-18):723-7. Review. Italian. No abstract available.

PMID:
3325796
47.

[Scoliosis (author's transl)].

Mastragostino S, Scarsi M.

Pediatr Med Chir. 1981 Jul-Aug;3(4):253-62. Italian.

PMID:
7343919
48.

[Ocular changes in rheumatoid arthritis].

Siliato F, Scarsi MR, Bonioli E, Patrone P, Cambiaso R, Gemme G.

Minerva Pediatr. 1978 Nov 30;30(22):1761-6. Italian. No abstract available.

PMID:
569251
49.

[Rhabdomyosarcoma of the orbit in childhood. Observation of 8 cases].

De Bernardi B, Vitale V, Comelli A, Scarsi MR, Cossu P, Vinante O.

Minerva Pediatr. 1978 Jan 31;30(2):147-53. Italian. No abstract available.

PMID:
642880
50.

Oculocutaneous tyrosinosis. Report of two cases in the same family.

Garibaldi LR, Siliato F, de Martini I, Scarsi MR, Romano C.

Helv Paediatr Acta. 1977 Jul;32(2):173-80.

PMID:
33934

Supplemental Content

Loading ...
Support Center